已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Microbiome–Obesity–Liver Cancer Interaction: Senescence of Hepatic Stellate Cells and Bile Acids Play New Roles

衰老 肝星状细胞 脂肪变性 内科学 肝细胞癌 非酒精性脂肪肝 癌症 肝癌 癌症研究 生物 内分泌学 医学 免疫学 疾病 脂肪肝
作者
Ekihiro Seki
出处
期刊:Gastroenterology [Elsevier BV]
卷期号:146 (3): 860-861 被引量:10
标识
DOI:10.1053/j.gastro.2014.01.029
摘要

Yoshimoto S, Loo TM, Atarashi K, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 2013;499:97–101.The increased prevalence of obesity is a significant health concern in developed countries. Epidemiologic human studies and experiments using rodents show that obesity is associated with not only the manifestations of metabolic disease, such as diabetes and cardiovascular disease, but also with increased incidence of a number of cancers, including hepatocellular carcinoma (HCC). The incidence of HCC is increased in patients with hepatosteatosis accompanied with liver inflammation (referred to as nonalcoholic steatohepatitis) rather than patients with simple steatosis. Emerging evidences demonstrate that intestinal microbiome is among the key components in the progression of obesity and HCC (Nature 2006;444:1027–1031; Cancer Cell 2012;21:504–516).Yoshimoto et al demonstrated that senescence-associated secretory phenotype (SASP) of hepatic stellate cells (HSC) induced by a bacterial byproduct, deoxycholic acid (DCA), promotes obesity-associated HCC progression. The study initiated to confirm that chemical toxin-induced Ras mutation causes HCC only in obese mice fed a high-fat diet. This phenotype was reproduced in genetically obese ob/ob mice. This study found that cellular senescence markers such as p21Waf1/Cip1 and p16INK4a, as well as DNA damage markers (53BP1 and γ-H2AX), were up-regulated in HCC lesions, particularly in HSC. These HSC produced SASP cytokines, such as interleukin (IL)-6, GROα, and CXCL9, in which proliferation was inhibited, demonstrating that HSC in HCC lesions has become senescent. Although HSC do not produce IL-1α, a SASP contributor, HSC induced the expression of inflammasome components and IL-1β. In IL-1β-/- mice, a high-fat diet induced hepatosteatosis and HSC senescence, as demonstrated by the expression of 53BP1 and p21; however, the production of SASP cytokines and HCC formation were suppressed, suggesting that SASP is essential for obesity-associated HCC development.The study then highlighted the contribution of intestinal microbiome to HCC development in mice. Gut sterilization by oral administration of antibiotics cocktail or vancomycin that targets Gram-positive bacteria significantly suppressed SASP of HSC and growth of HCC. They also found that serum levels of DCA and the composition of Clostridium cluster XI and XIVa that convert primary bile acids to DCA were increased in obese mice, but the DCA content was decreased by antibiotic treatment. Because DCA produces reactive oxygen species that cause DNA damage and SASP, the researchers then focused on the crucial role of DCA in obesity-associated HCC growth. High-fat diet–driven HCC growth was dramatically suppressed by lowering DCA levels by administrations of difructose anhydride III, which inhibits 7α-dehydroxylation activity or by ursodeoxycholic acid, which promotes bile acid secretion. Conversely, oral DCA feeding enhanced HCC development along with HSC senescence and SASP in obese mice. Finally, the study confirmed the presence of senescent HSC and SASP in HCC developed in nonalcoholic steatohepatitis patients.CommentObesity and excessive nutrient consumption can promote HCC development, which has been shown in epidemiologic human studies as well as animal experiments (Hepatology 2010;51:1820–1832; Cell 2010;140:197–208). Obesity is known as systemic inflammatory disease. Proinflammatory cytokines, such as tumor necrosis factor-α and IL-6 released from adipose tissues and liver macrophages may contribute to the progression of nonalcoholic fatty liver disease. Reactive oxygen species produced during fatty acid β-oxidation or by stimulation with saturated free fatty acids also participate in nonalcoholic fatty liver disease development (Annu Rev Pathol 2010;5:145–171). In addition, overgrowth and changes in the composition of intestinal microbiome are associated with obesity (Hepatology 2013;58:120–127). The study done by Yoshimoto et al demonstrates that DCA, a metabolite of intestinal microbiome, causes DNA damage that induces SASP in HSC, resulting in the promotion of obesity-associated HCC.One of their unique hypotheses is that HSC senescence and SASP-related cytokines promote obesity-associated HCC. Cellular senescence is a protective mechanism against tumorigenesis (Nat Rev Cancer 2009;9:81–94). Telomerase shortening, DNA damage, and oncogene activation, such as Kras and Braf, participate in the induction of cellular senescence. Senescence-induced cell-cycle arrest and apoptosis prevent malignant transformation and malignant cell growth. Yoshimoto et al found a number of p21-expressing senescent cells in HCC lesions, and determined that those cells are mainly HSC. HSC exhibit proinflammatory phenotype rather than fibrogenic phenotype during senescence (Hepatology 2003;37:653–664). In this context, proinflammatory cytokines, such as IL-6, GROα, and CXCL9, produced from senescent HSC promote obesity-associated HCC. The researchers concluded that the responsible cells that produce SASP cytokines are senescent HSC, but not Kupffer cells, which are the major proinflammatory cytokine-producing cells in the liver. This hypothesis contradicts previous studies reported by Karin et al, demonstrating that Kupffer cells are the source of proinflammatory cytokines driving HCC development (Science 2007;317:212–214; Cell 2010;140:197–208). Alternatively, Schwabe et al have reported that intestinal microbiome-dependent TLR4-dependent profibrogenic response and epiregulin production in HSC contribute to fibrosis-associated HCC progression (Cancer Cell 2012;21:504–516). Intriguingly, the study done by Lujambio et al demonstrates another hypothesis for HCC development associated with HSC senescence (Cell 2013;153:449–460). p53 is a tumor suppressor and senescence mediator associated with cell-cycle arrest and apoptosis. Lujambio et al generated HSC-specific p53-deficient mice in which HSC do not undergo senescence. Mice with p53-deficient HSC produced more liver cirrhosis and accelerated HCC growth, indicating that HSC senescence suppresses liver fibrosis and HCC development. Moreover, the study found that p53-null HSC changed macrophage polarization to M2 phenotype. This hypothesis is contradictory to the hypothesis proposed by Yoshimoto et al.Yoshimoto et al also demonstrate an intriguing observation that fibrosis does not contribute to obesity-associated HCC promotion. Although HSP47 is a specific molecular chaperone for assembly of collagen fibers, knocking down HSP47 in vivo reduces HCC growth. This suggests that HSP47 may have functions other than collagen assembly as a molecular chaperon, such as induction of HSC apoptosis (Nat Biotechnol 2008;26:431–442). Further investigations, such as using HSC-specific deletion technology, are required to answer the question whether HSC are the responsible cell types to promote the development of obesity-associated HCC.Another key discovery of this paper is the contribution of intestinal microbiome to promotion of obesity-associated HCC. Although the changes in the composition of intestinal microbiota in obese population have been shown (Nature 2006;444:1027–1031), the mechanism is still unclear. Schwabe et al showed that TLR4 ligand, such as lipopolysaccharide, released from intestinal microbiome is a crucial component to promote fibrosis-associated HCC through HSC activation (Cancer Cell 2012;21:504–516). However, Yoshimoto’s study demonstrated that TLR4 deficiency does not protect mice from obesity-associated HCC. Instead, they found that microbial byproduct DCA was generated as secondary bile acids through Clostridium in obese mice. DCA is known to induce reactive oxygen species production and causes genotoxic DNA damage as a potential carcinogen. DCA content is increased in feces from humans who consumed a high-fat, Western-style diet. Although the authors found that DCA causes HSC senescence, the direct effect of DCA on hepatocytes to malignant transformation has yet to be noted. In addition, the mechanism of DCA-induced HSC senescence is unclear. Bile acid receptors FXR and TGR5 may contribute to DCA-induced HSC senescence. Although the proposed role of HSC senescence on hepatocarcinogenesis is controversial with other studies, this paper undoubtedly demonstrates a novel pathophysiologic link between gram-positive bacteria-dependent DCA generation and obesity-associated HCC growth. This discovery provides the new idea to develop effective therapies and prevention targeting HSC senescence, bile acids and intestinal microbiome for nonalcoholic fatty liver disease-mediated HCC. Yoshimoto S, Loo TM, Atarashi K, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 2013;499:97–101. The increased prevalence of obesity is a significant health concern in developed countries. Epidemiologic human studies and experiments using rodents show that obesity is associated with not only the manifestations of metabolic disease, such as diabetes and cardiovascular disease, but also with increased incidence of a number of cancers, including hepatocellular carcinoma (HCC). The incidence of HCC is increased in patients with hepatosteatosis accompanied with liver inflammation (referred to as nonalcoholic steatohepatitis) rather than patients with simple steatosis. Emerging evidences demonstrate that intestinal microbiome is among the key components in the progression of obesity and HCC (Nature 2006;444:1027–1031; Cancer Cell 2012;21:504–516). Yoshimoto et al demonstrated that senescence-associated secretory phenotype (SASP) of hepatic stellate cells (HSC) induced by a bacterial byproduct, deoxycholic acid (DCA), promotes obesity-associated HCC progression. The study initiated to confirm that chemical toxin-induced Ras mutation causes HCC only in obese mice fed a high-fat diet. This phenotype was reproduced in genetically obese ob/ob mice. This study found that cellular senescence markers such as p21Waf1/Cip1 and p16INK4a, as well as DNA damage markers (53BP1 and γ-H2AX), were up-regulated in HCC lesions, particularly in HSC. These HSC produced SASP cytokines, such as interleukin (IL)-6, GROα, and CXCL9, in which proliferation was inhibited, demonstrating that HSC in HCC lesions has become senescent. Although HSC do not produce IL-1α, a SASP contributor, HSC induced the expression of inflammasome components and IL-1β. In IL-1β-/- mice, a high-fat diet induced hepatosteatosis and HSC senescence, as demonstrated by the expression of 53BP1 and p21; however, the production of SASP cytokines and HCC formation were suppressed, suggesting that SASP is essential for obesity-associated HCC development. The study then highlighted the contribution of intestinal microbiome to HCC development in mice. Gut sterilization by oral administration of antibiotics cocktail or vancomycin that targets Gram-positive bacteria significantly suppressed SASP of HSC and growth of HCC. They also found that serum levels of DCA and the composition of Clostridium cluster XI and XIVa that convert primary bile acids to DCA were increased in obese mice, but the DCA content was decreased by antibiotic treatment. Because DCA produces reactive oxygen species that cause DNA damage and SASP, the researchers then focused on the crucial role of DCA in obesity-associated HCC growth. High-fat diet–driven HCC growth was dramatically suppressed by lowering DCA levels by administrations of difructose anhydride III, which inhibits 7α-dehydroxylation activity or by ursodeoxycholic acid, which promotes bile acid secretion. Conversely, oral DCA feeding enhanced HCC development along with HSC senescence and SASP in obese mice. Finally, the study confirmed the presence of senescent HSC and SASP in HCC developed in nonalcoholic steatohepatitis patients. CommentObesity and excessive nutrient consumption can promote HCC development, which has been shown in epidemiologic human studies as well as animal experiments (Hepatology 2010;51:1820–1832; Cell 2010;140:197–208). Obesity is known as systemic inflammatory disease. Proinflammatory cytokines, such as tumor necrosis factor-α and IL-6 released from adipose tissues and liver macrophages may contribute to the progression of nonalcoholic fatty liver disease. Reactive oxygen species produced during fatty acid β-oxidation or by stimulation with saturated free fatty acids also participate in nonalcoholic fatty liver disease development (Annu Rev Pathol 2010;5:145–171). In addition, overgrowth and changes in the composition of intestinal microbiome are associated with obesity (Hepatology 2013;58:120–127). The study done by Yoshimoto et al demonstrates that DCA, a metabolite of intestinal microbiome, causes DNA damage that induces SASP in HSC, resulting in the promotion of obesity-associated HCC.One of their unique hypotheses is that HSC senescence and SASP-related cytokines promote obesity-associated HCC. Cellular senescence is a protective mechanism against tumorigenesis (Nat Rev Cancer 2009;9:81–94). Telomerase shortening, DNA damage, and oncogene activation, such as Kras and Braf, participate in the induction of cellular senescence. Senescence-induced cell-cycle arrest and apoptosis prevent malignant transformation and malignant cell growth. Yoshimoto et al found a number of p21-expressing senescent cells in HCC lesions, and determined that those cells are mainly HSC. HSC exhibit proinflammatory phenotype rather than fibrogenic phenotype during senescence (Hepatology 2003;37:653–664). In this context, proinflammatory cytokines, such as IL-6, GROα, and CXCL9, produced from senescent HSC promote obesity-associated HCC. The researchers concluded that the responsible cells that produce SASP cytokines are senescent HSC, but not Kupffer cells, which are the major proinflammatory cytokine-producing cells in the liver. This hypothesis contradicts previous studies reported by Karin et al, demonstrating that Kupffer cells are the source of proinflammatory cytokines driving HCC development (Science 2007;317:212–214; Cell 2010;140:197–208). Alternatively, Schwabe et al have reported that intestinal microbiome-dependent TLR4-dependent profibrogenic response and epiregulin production in HSC contribute to fibrosis-associated HCC progression (Cancer Cell 2012;21:504–516). Intriguingly, the study done by Lujambio et al demonstrates another hypothesis for HCC development associated with HSC senescence (Cell 2013;153:449–460). p53 is a tumor suppressor and senescence mediator associated with cell-cycle arrest and apoptosis. Lujambio et al generated HSC-specific p53-deficient mice in which HSC do not undergo senescence. Mice with p53-deficient HSC produced more liver cirrhosis and accelerated HCC growth, indicating that HSC senescence suppresses liver fibrosis and HCC development. Moreover, the study found that p53-null HSC changed macrophage polarization to M2 phenotype. This hypothesis is contradictory to the hypothesis proposed by Yoshimoto et al.Yoshimoto et al also demonstrate an intriguing observation that fibrosis does not contribute to obesity-associated HCC promotion. Although HSP47 is a specific molecular chaperone for assembly of collagen fibers, knocking down HSP47 in vivo reduces HCC growth. This suggests that HSP47 may have functions other than collagen assembly as a molecular chaperon, such as induction of HSC apoptosis (Nat Biotechnol 2008;26:431–442). Further investigations, such as using HSC-specific deletion technology, are required to answer the question whether HSC are the responsible cell types to promote the development of obesity-associated HCC.Another key discovery of this paper is the contribution of intestinal microbiome to promotion of obesity-associated HCC. Although the changes in the composition of intestinal microbiota in obese population have been shown (Nature 2006;444:1027–1031), the mechanism is still unclear. Schwabe et al showed that TLR4 ligand, such as lipopolysaccharide, released from intestinal microbiome is a crucial component to promote fibrosis-associated HCC through HSC activation (Cancer Cell 2012;21:504–516). However, Yoshimoto’s study demonstrated that TLR4 deficiency does not protect mice from obesity-associated HCC. Instead, they found that microbial byproduct DCA was generated as secondary bile acids through Clostridium in obese mice. DCA is known to induce reactive oxygen species production and causes genotoxic DNA damage as a potential carcinogen. DCA content is increased in feces from humans who consumed a high-fat, Western-style diet. Although the authors found that DCA causes HSC senescence, the direct effect of DCA on hepatocytes to malignant transformation has yet to be noted. In addition, the mechanism of DCA-induced HSC senescence is unclear. Bile acid receptors FXR and TGR5 may contribute to DCA-induced HSC senescence. Although the proposed role of HSC senescence on hepatocarcinogenesis is controversial with other studies, this paper undoubtedly demonstrates a novel pathophysiologic link between gram-positive bacteria-dependent DCA generation and obesity-associated HCC growth. This discovery provides the new idea to develop effective therapies and prevention targeting HSC senescence, bile acids and intestinal microbiome for nonalcoholic fatty liver disease-mediated HCC. Obesity and excessive nutrient consumption can promote HCC development, which has been shown in epidemiologic human studies as well as animal experiments (Hepatology 2010;51:1820–1832; Cell 2010;140:197–208). Obesity is known as systemic inflammatory disease. Proinflammatory cytokines, such as tumor necrosis factor-α and IL-6 released from adipose tissues and liver macrophages may contribute to the progression of nonalcoholic fatty liver disease. Reactive oxygen species produced during fatty acid β-oxidation or by stimulation with saturated free fatty acids also participate in nonalcoholic fatty liver disease development (Annu Rev Pathol 2010;5:145–171). In addition, overgrowth and changes in the composition of intestinal microbiome are associated with obesity (Hepatology 2013;58:120–127). The study done by Yoshimoto et al demonstrates that DCA, a metabolite of intestinal microbiome, causes DNA damage that induces SASP in HSC, resulting in the promotion of obesity-associated HCC. One of their unique hypotheses is that HSC senescence and SASP-related cytokines promote obesity-associated HCC. Cellular senescence is a protective mechanism against tumorigenesis (Nat Rev Cancer 2009;9:81–94). Telomerase shortening, DNA damage, and oncogene activation, such as Kras and Braf, participate in the induction of cellular senescence. Senescence-induced cell-cycle arrest and apoptosis prevent malignant transformation and malignant cell growth. Yoshimoto et al found a number of p21-expressing senescent cells in HCC lesions, and determined that those cells are mainly HSC. HSC exhibit proinflammatory phenotype rather than fibrogenic phenotype during senescence (Hepatology 2003;37:653–664). In this context, proinflammatory cytokines, such as IL-6, GROα, and CXCL9, produced from senescent HSC promote obesity-associated HCC. The researchers concluded that the responsible cells that produce SASP cytokines are senescent HSC, but not Kupffer cells, which are the major proinflammatory cytokine-producing cells in the liver. This hypothesis contradicts previous studies reported by Karin et al, demonstrating that Kupffer cells are the source of proinflammatory cytokines driving HCC development (Science 2007;317:212–214; Cell 2010;140:197–208). Alternatively, Schwabe et al have reported that intestinal microbiome-dependent TLR4-dependent profibrogenic response and epiregulin production in HSC contribute to fibrosis-associated HCC progression (Cancer Cell 2012;21:504–516). Intriguingly, the study done by Lujambio et al demonstrates another hypothesis for HCC development associated with HSC senescence (Cell 2013;153:449–460). p53 is a tumor suppressor and senescence mediator associated with cell-cycle arrest and apoptosis. Lujambio et al generated HSC-specific p53-deficient mice in which HSC do not undergo senescence. Mice with p53-deficient HSC produced more liver cirrhosis and accelerated HCC growth, indicating that HSC senescence suppresses liver fibrosis and HCC development. Moreover, the study found that p53-null HSC changed macrophage polarization to M2 phenotype. This hypothesis is contradictory to the hypothesis proposed by Yoshimoto et al. Yoshimoto et al also demonstrate an intriguing observation that fibrosis does not contribute to obesity-associated HCC promotion. Although HSP47 is a specific molecular chaperone for assembly of collagen fibers, knocking down HSP47 in vivo reduces HCC growth. This suggests that HSP47 may have functions other than collagen assembly as a molecular chaperon, such as induction of HSC apoptosis (Nat Biotechnol 2008;26:431–442). Further investigations, such as using HSC-specific deletion technology, are required to answer the question whether HSC are the responsible cell types to promote the development of obesity-associated HCC. Another key discovery of this paper is the contribution of intestinal microbiome to promotion of obesity-associated HCC. Although the changes in the composition of intestinal microbiota in obese population have been shown (Nature 2006;444:1027–1031), the mechanism is still unclear. Schwabe et al showed that TLR4 ligand, such as lipopolysaccharide, released from intestinal microbiome is a crucial component to promote fibrosis-associated HCC through HSC activation (Cancer Cell 2012;21:504–516). However, Yoshimoto’s study demonstrated that TLR4 deficiency does not protect mice from obesity-associated HCC. Instead, they found that microbial byproduct DCA was generated as secondary bile acids through Clostridium in obese mice. DCA is known to induce reactive oxygen species production and causes genotoxic DNA damage as a potential carcinogen. DCA content is increased in feces from humans who consumed a high-fat, Western-style diet. Although the authors found that DCA causes HSC senescence, the direct effect of DCA on hepatocytes to malignant transformation has yet to be noted. In addition, the mechanism of DCA-induced HSC senescence is unclear. Bile acid receptors FXR and TGR5 may contribute to DCA-induced HSC senescence. Although the proposed role of HSC senescence on hepatocarcinogenesis is controversial with other studies, this paper undoubtedly demonstrates a novel pathophysiologic link between gram-positive bacteria-dependent DCA generation and obesity-associated HCC growth. This discovery provides the new idea to develop effective therapies and prevention targeting HSC senescence, bile acids and intestinal microbiome for nonalcoholic fatty liver disease-mediated HCC.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Xi完成签到 ,获得积分10
刚刚
刚刚
阿盖完成签到,获得积分20
刚刚
yzr01发布了新的文献求助10
1秒前
于66发布了新的文献求助10
1秒前
涣醒发布了新的文献求助10
2秒前
关尔匕禾页完成签到,获得积分10
2秒前
Ava的应助被怀玉不折采纳,获得10
2秒前
Lucas的应助被瓯哥采纳,获得10
3秒前
NexusExplorer的应助被孙朱珠采纳,获得10
3秒前
3秒前
3秒前
yzr01发布了新的文献求助10
3秒前
4秒前
wy完成签到 ,获得积分10
4秒前
Dy完成签到,获得积分10
4秒前
5秒前
徐XU完成签到 ,获得积分10
5秒前
纯情的阁的应助被mmmm采纳,获得340
6秒前
6秒前
yzr01发布了新的文献求助10
6秒前
落寞幻翠发布了新的文献求助10
6秒前
6秒前
大个的应助被悲喜自渡采纳,获得10
7秒前
7秒前
好好学习完成签到 ,获得积分10
7秒前
AriaL发布了新的文献求助10
8秒前
yzr01发布了新的文献求助10
8秒前
小蘑菇的应助被旺仔QQ糖采纳,获得10
8秒前
暮念完成签到,获得积分10
8秒前
9秒前
rayan完成签到 ,获得积分10
9秒前
aaa发布了新的文献求助10
10秒前
yzr01发布了新的文献求助10
10秒前
11秒前
5566妈完成签到,获得积分10
11秒前
11秒前
ihan完成签到,获得积分10
12秒前
12秒前
Lancelot发布了新的文献求助10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158064
求助须知:如何正确求助?哪些是违规求助? 9553987
关于积分的说明 21716926
捐赠科研通 7747422
什么是DOI,文献DOI怎么找? 3426934
关于科研通互助平台的介绍 2551676
邀请新用户注册赠送积分活动 2471057